Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1812
Gene Symbol: DRD1
DRD1
0.010 GeneticVariation phenotype BEFREE We report here the effect of maternal age and the age of the mother at the birth of her first child (maternal age 1st) as epistatic factors for the interaction of the dopamine D1 gene (DRD1) with obsessive-compulsive behaviors and with stuttering. 16342283 2006
Entrez Id: 1798
Gene Symbol: DPAGT1
DPAGT1
0.010 GeneticVariation phenotype BEFREE We identified a missense mutation in the N-acetylglucosamine-1-phosphate transferase gene (GNPTAB), which encodes the alpha and beta catalytic subunits of GlcNAc-phosphotransferase (GNPT [EC 2.7.8.15]), that was associated with stuttering in a large, consanguineous Pakistani family. 20147709 2010
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 Biomarker phenotype BEFREE We found that the μ4 subunit of AP-4 interacts with NAGPA, an enzyme involved in the synthesis of the mannose 6-phosphate signal that targets acid hydrolases to the lysosome and the product of a gene previously associated with stuttering. 26544806 2015
Entrez Id: 2904
Gene Symbol: GRIN2B
GRIN2B
0.010 AlteredExpression phenotype BEFREE We found that increased NR2B expression in adult LMAN induced increases in song sequence diversity and slower song tempo more similar to juvenile songs, but also increased syllable repetitions similar to stuttering. 28432288 2017
Entrez Id: 84572
Gene Symbol: GNPTG
GNPTG
0.020 Biomarker phenotype BEFREE We found that GNPTG - a gene involved in the mannose-6-phosphate lysosomal targeting pathways - was significantly co-localized with the stuttering cortical network. 31669185 2020
Entrez Id: 9021
Gene Symbol: SOCS3
SOCS3
0.010 Biomarker phenotype BEFREE We also aimed to study how the new subjective self-reports of the SSI-4 complement the stuttering severity score obtained from the SSI-3 or the SSI-4. 29723653 2019
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 Biomarker phenotype BEFREE This was compared to the distribution of variants in the GNPTAB, GNPTG, and NAGPA genes which have previously been associated with persistent stuttering. 24807205 2014
Entrez Id: 26047
Gene Symbol: CNTNAP2
CNTNAP2
0.320 Biomarker phenotype BEFREE This study provides an improved estimate of the contribution of mutations in GNPTAB, GNPTG and NAGPA to persistent stuttering, and suggests that variants in FOXP2 and CNTNAP2 are not involved in the genesis of familial persistent stuttering. 24807205 2014
Entrez Id: 93986
Gene Symbol: FOXP2
FOXP2
0.030 GeneticVariation phenotype BEFREE This study provides an improved estimate of the contribution of mutations in GNPTAB, GNPTG and NAGPA to persistent stuttering, and suggests that variants in FOXP2 and CNTNAP2 are not involved in the genesis of familial persistent stuttering. 24807205 2014
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.030 GeneticVariation phenotype BEFREE This idea is supported by an additional path model showing that the polymorphism DRD2 C957T influences the self-reported severity of stuttering mainly by its influence on neuroticism (independent of the variable sex). 22262089 2012
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.040 GeneticVariation phenotype BEFREE This and three other mutations in GNPTAB occurred in unrelated subjects with stuttering but not in control subjects. 20147709 2010
Entrez Id: 9306
Gene Symbol: SOCS6
SOCS6
0.020 Biomarker phenotype BEFREE Thirty five PWS from ages 17 to 42 were recruited and 10 speech and language pathologists assessed their stuttering severity using either the SSI-4 or stuttering severity ratings (SR) to test validity and reliability of the Persian translated version. 29723653 2019
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 GeneticVariation phenotype BEFREE These biochemical findings extend the genetic data implicating mutations in the NAGPA gene in the persistent stuttering phenotype. 21956109 2011
Entrez Id: 9306
Gene Symbol: SOCS6
SOCS6
0.020 GeneticVariation phenotype BEFREE The severity of stuttering (low, moderate, and severe) were assessed using Stuttering Severity Instrument, Fourth edition (SSI-4). 30055725 2018
Entrez Id: 6462
Gene Symbol: SHBG
SHBG
0.010 AlteredExpression phenotype BEFREE The severity of stuttering was positively correlated with the serum levels of testosterone, DHEA, and cortisol, whereas no association was seen between the stuttering and digit ratio, progesterone, or SHBG. 28992603 2017
Entrez Id: 23431
Gene Symbol: AP4E1
AP4E1
0.110 GeneticVariation phenotype BEFREE The rate of rare variants in AP4E1 was significantly higher in unrelated Pakistani and Cameroonian stuttering individuals than in population-matched control individuals, and coding variants in this gene are exceptionally rare in the general sub-Saharan West African, South Asian, and North American populations. 26544806 2015
Entrez Id: 182
Gene Symbol: JAG1
JAG1
0.010 Biomarker phenotype BEFREE The purpose of this study was to investigate the influence of phonetic complexity as measured by the Word Complexity Measure (WCM) on the speed of single-word production in adults who do (AWS, n=15) and do not stutter (AWNS, n=15). 28886431 2017
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.030 GeneticVariation phenotype BEFREE The allele frequencies of DRD2 C957T were not significantly different between the CWS and the CWNS; however, the frequency of the TT genotype was significantly higher among the CWS (p = 0.02), which was associated with 2.25-fold susceptibility to stuttering (OR = 2.25, 95% CI = 1.03 to 4.90, p = 0.04). 30199750 2019
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 GeneticVariation phenotype BEFREE Surprisingly, the first variant genes to be associated with stuttering are those encoding the lysosomal targeting system, GNPTAB, GNPTG, and NAGPA. 22884963 2012
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.040 GeneticVariation phenotype BEFREE Surprisingly, the first variant genes to be associated with stuttering are those encoding the lysosomal targeting system, GNPTAB, GNPTG, and NAGPA. 22884963 2012
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 Biomarker phenotype BEFREE Recently, variants in GNPTAB, GNPTG, and the functionally related NAGPA gene have been associated with non-syndromic persistent stuttering. 26130485 2016
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.010 Biomarker phenotype BEFREE Practitioners should be aware that iNPH can present with stuttering, and that CSF drainage can improve stuttering in select circumstances. 31805405 2020
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.010 Biomarker phenotype BEFREE Practitioners should be aware that iNPH can present with stuttering, and that CSF drainage can improve stuttering in select circumstances. 31805405 2020
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 GeneticVariation phenotype BEFREE Our results revealed that the stuttering risk genes GNPTAB and NAGPA might also associate with developmental dyslexia in the Chinese population. 25643770 2015
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.040 GeneticVariation phenotype BEFREE Our results revealed that the stuttering risk genes GNPTAB and NAGPA might also associate with developmental dyslexia in the Chinese population. 25643770 2015